PGRMC1: an enigmatic heme-binding protein
MR McGuire, PJ Espenshade - Pharmacology & therapeutics, 2023 - Elsevier
Abstract Progesterone Receptor Membrane Component 1 (PGRMC1) is a heme-binding
protein that has been implicated in a wide range of cell and tissue functions, including …
protein that has been implicated in a wide range of cell and tissue functions, including …
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers
Cancer is one of the most common causes of death worldwide, and its development is a
result of the complex interaction of genetic factors, environmental cues, and aging. Hormone …
result of the complex interaction of genetic factors, environmental cues, and aging. Hormone …
Membrane progesterone receptors (mPRs/PAQRs) are going beyond its initial definitions
J Aickareth, M Hawwar, N Sanchez, R Gnanasekaran… - Membranes, 2023 - mdpi.com
Progesterone (PRG) is a key cyclical reproductive hormone that has a significant impact on
female organs in vertebrates. It is mainly produced by the corpus luteum of the ovaries, but …
female organs in vertebrates. It is mainly produced by the corpus luteum of the ovaries, but …
Sigma receptors: Novel regulators of iron/heme homeostasis and ferroptosis
NT Nguyen, V Jaramillo-Martinez, M Mathew… - International Journal of …, 2023 - mdpi.com
Sigma receptors are non-opiate/non-phencyclidine receptors that bind progesterone and/or
heme and also several unrelated xenobiotics/chemicals. They reside in the plasma …
heme and also several unrelated xenobiotics/chemicals. They reside in the plasma …
New Insights on the Progesterone (P4) and PGRMC1/NENF Complex Interactions in Colorectal Cancer Progression
J Kamińska, OM Koper-Lenkiewicz… - Cancers, 2023 - mdpi.com
Simple Summary Progesterone (P4) via PGRMC1/NENF may stimulate the proliferation and
invasion of colorectal cancer DLD-1 and HT-29 cells. PGRMC1 inhibition abolishes the …
invasion of colorectal cancer DLD-1 and HT-29 cells. PGRMC1 inhibition abolishes the …
Defining Requirements for Heme Binding in PGRMC1 and Identifying Key Elements That Influence Protein Dimerization
Progesterone receptor membrane component 1 (PGRMC1) binds heme via a surface-
exposed site and displays some structural resemblance to cytochrome b5 despite their …
exposed site and displays some structural resemblance to cytochrome b5 despite their …
PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis
Y Zhao, X Ruan, J Cheng, X Xu, M Gu, AO Mueck - Climacteric, 2023 - Taylor & Francis
Objective Triple-negative breast cancer (TNBC) is the most malignant form of breast cancer
with increasing incidence and mortality worldwide. The progesterone receptor membrane …
with increasing incidence and mortality worldwide. The progesterone receptor membrane …
Downregulation of PGRMC1 accelerates differentiation and fusion of a human trophoblast cell line
A Tsuru, M Yoshie, M Suzuki… - Journal of …, 2024 - joe.bioscientifica.com
Mononuclear cytotrophoblasts (CTs) differentiate and fuse to form multinuclear
syncytiotrophoblasts (STs), which produce human chorionic gonadotropin (hCG) and …
syncytiotrophoblasts (STs), which produce human chorionic gonadotropin (hCG) and …
[HTML][HTML] Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells
Progestins used in hormonal contraceptives and menopausal hormone therapy (MHT) have
been linked to increased breast cancer risk. Whether the association holds for all progestins …
been linked to increased breast cancer risk. Whether the association holds for all progestins …
AG-205 upregulates enzymes involved in cholesterol biosynthesis and steroidogenesis in human endometrial cells independently of PGRMC1 and related MAPR …
C Thieffry, M Van Wynendaele, A Aynaci, M Maja… - Biomolecules, 2021 - mdpi.com
An inappropriate response to progestogens in the human endometrium can result in fertility
issues and jeopardize progestin-based treatments against pathologies such as …
issues and jeopardize progestin-based treatments against pathologies such as …